Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06016946 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

Study acronym: UNIFAI
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contacts updated at 4 of 34 sitesv17
  2. Study sites revised (34)v16
  3. Site details revised at 8 of 34 sitesv15
  4. Site contacts updated at 4 of 34 sitesv14
  5. Site details revised at 7 of 34 sitesv13
Show 11 earlier versionsHide 11 earlier versions
  1. Study sites revised (34)v12
  2. Site details revised at 4 of 34 sitesv11
  3. Site details revised at 5 of 34 sitesv10
  4. Site details revised at 4 of 34 sitesv9
  5. Study description expanded, about 6 wordsv8
  6. Study sites: 32 to 34v7
  7. Site contacts updated at 1 of 32 sitesv6
  8. Site details revised at 2 of 32 sitesv5
  9. Study sites revised (32)v4
  10. Site details revised at 3 of 32 sitesv3
  11. Study sites: 14 to 32v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project is a global, multicenter, prospective, longitudinal, observational natural history study that can be used to understand the disease progression and support the development of safe and effective drugs and biological products for Friedreich ataxia.
Trial Details
NCT Number NCT06016946
Lead Sponsor Friedreich's Ataxia Research Alliance
Conditions
(from sponsor)		 Friedreich Ataxia
Related terms Ataxia, Friedreich Ataxia, Genetic Diseases, Inborn, Neurodegenerative Diseases, Neurologic Manifestations, Rare Diseases
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov